HARBOR CAPITAL ADVISORS, INC.

Position in JNJ — Johnson & Johnson

CIK 1039128 CHICAGO, IL

Position in JNJ

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$7,154,842

+$362,099 QoQ

Shares Held

28,172

+1.4% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.56%

of 13F equity value

Holder Rank

#1,328

of 4,676 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HARBOR CAPITAL ADVISORS, INC. holds $35,051,660 across 8 Drug Manufacturers - General names. JNJ ranks #2 (20.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	10,271	$12,319,346
2	JNJ	Johnson & Johnson This page	28,172	$7,154,842
3	ABBV	AbbVie Inc.	20,794	$5,232,602
4	MRK	Merck & Co., Inc.	27,785	$3,570,372
5	OGN	Organon & Co.	214,639	$2,906,212
6	AMGN	Amgen Inc	6,049	$2,190,463
7	PFE	Pfizer Inc	66,351	$1,597,732
8	BMY	Bristol Myers Squibb Co	1,390	$80,091

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$7,154,842	28,172	+1.4%	Shares	Sole	2026-08-07
2026-03-31	$6,792,743	27,789	-23.5%	Shares	Sole	2026-04-28
2025-12-31	$7,518,286	36,329	-0.4%	Shares	Sole	2026-01-20
2025-09-30	$6,761,154	36,464	+4.8%	Shares	Sole	2025-10-15
2025-06-30	$5,314,019	34,789	-0.2%	Shares	Sole	2025-07-09
2025-03-31	$5,780,850	34,858	-30.1%	Shares	Sole	2025-04-14
2024-12-31	$7,213,500	49,879	+2.5%	Shares	Sole	2025-01-10
2024-09-30	$7,885,029	48,655	+0.5%	Shares	Sole	2024-10-29
2024-06-30	$7,077,944	48,426	+0.2%	Shares	Sole	2024-07-09
2024-03-31	$7,645,322	48,330	+3.7%	Shares	Sole	2024-05-13
2023-12-31	$7,303,613	46,597	-0.2%	Shares	Sole	2024-01-08
2023-09-30	$7,268,541	46,668	+0.1%	Shares	Sole	2023-10-20
2023-06-30	$7,718,363	46,631	-0.2%	Shares	Sole	2023-07-11
2023-03-31	$7,241,600	46,720	—	Shares	Sole	2023-04-26
No filing history on record for this holder in this stock.